PKC-dependent superoxide production by the renal medullary thick ascending limb from diabetic rats

Jing Yang, Pascale H. Lane, Jennifer S. Pollock, Pamela K Carmines

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Type 1 diabetes (T1D) is a state of oxidative stress accompanied by PKC activation in many tissues. The primary site of O2•- production by the normal rat kidney is the medullary thick ascending limb (mTAL). We hypothesized that T1D increases O2•- production by the mTAL through a PKC-dependent mechanism involving increased expression and translocation of one or more PKC isoforms. mTAL suspensions were prepared from rats with streptozotocin-induced T1D (STZ mTALs) and from normal or sham rats (normal/sham mTALs). O2•- production by STZ mTALs was fivefold higher than normal/sham mTALs (P < 0.05). PMA (30 min) mimicked the effect of T1D on O2•- production. Exposure to calphostin C or chelerythrine (PKC inhibitors), Gö6976 (PKCα/β inhibitor), or rottlerin (PKCδ inhibitor) decreased O2•- production to <20% of untreated baseline in both normal/sham and STZ mTALs. PKCβ inhibitors had no effect. PKC activity was increased in STZ mTALs (P < 0.05 vs. normal/sham mTALs) and was unaltered by antioxidant exposure (tempol). PKCα protein levels were increased by 70% in STZ mTALs, with a ∼30% increase in the fraction associated with the membrane (both P < 0.05 vs. sham). PKCβ protein levels were elevated by 29% in STZ mTALs (P < 0.05 vs. sham) with no change in the membrane-bound fraction. Neither PKCδ protein levels nor its membrane-bound fraction differed between groups. Thus STZ mTALs display PKC activation, upregulation of PKCα and PKCβ protein levels, increased PKCα translocation to the membrane, and accelerated O2 •- production that is eradicated by inhibition of PKCα or PKCδ (but not PKCβ). We conclude that increased PKCα expression and activity are primarily responsible for PKC-dependent O2 •- production by the mTAL during T1D.

Original languageEnglish (US)
Pages (from-to)F1220-F1228
JournalAmerican Journal of Physiology - Renal Physiology
Volume297
Issue number5
DOIs
StatePublished - Nov 1 2009

Fingerprint

Type 1 Diabetes Mellitus
Superoxides
Extremities
Kidney
Membranes
Proteins
Streptozocin
Suspensions
Protein Isoforms
Oxidative Stress
Up-Regulation
Antioxidants

Keywords

  • Calphostin C
  • Chelerythrine
  • Diabetes mellitus
  • Gö6976
  • Rottlerin

ASJC Scopus subject areas

  • Physiology
  • Urology

Cite this

PKC-dependent superoxide production by the renal medullary thick ascending limb from diabetic rats. / Yang, Jing; Lane, Pascale H.; Pollock, Jennifer S.; Carmines, Pamela K.

In: American Journal of Physiology - Renal Physiology, Vol. 297, No. 5, 01.11.2009, p. F1220-F1228.

Research output: Contribution to journalArticle

@article{29c037dc18f948849ab7d435836c83ad,
title = "PKC-dependent superoxide production by the renal medullary thick ascending limb from diabetic rats",
abstract = "Type 1 diabetes (T1D) is a state of oxidative stress accompanied by PKC activation in many tissues. The primary site of O2•- production by the normal rat kidney is the medullary thick ascending limb (mTAL). We hypothesized that T1D increases O2•- production by the mTAL through a PKC-dependent mechanism involving increased expression and translocation of one or more PKC isoforms. mTAL suspensions were prepared from rats with streptozotocin-induced T1D (STZ mTALs) and from normal or sham rats (normal/sham mTALs). O2•- production by STZ mTALs was fivefold higher than normal/sham mTALs (P < 0.05). PMA (30 min) mimicked the effect of T1D on O2•- production. Exposure to calphostin C or chelerythrine (PKC inhibitors), G{\"o}6976 (PKCα/β inhibitor), or rottlerin (PKCδ inhibitor) decreased O2•- production to <20{\%} of untreated baseline in both normal/sham and STZ mTALs. PKCβ inhibitors had no effect. PKC activity was increased in STZ mTALs (P < 0.05 vs. normal/sham mTALs) and was unaltered by antioxidant exposure (tempol). PKCα protein levels were increased by 70{\%} in STZ mTALs, with a ∼30{\%} increase in the fraction associated with the membrane (both P < 0.05 vs. sham). PKCβ protein levels were elevated by 29{\%} in STZ mTALs (P < 0.05 vs. sham) with no change in the membrane-bound fraction. Neither PKCδ protein levels nor its membrane-bound fraction differed between groups. Thus STZ mTALs display PKC activation, upregulation of PKCα and PKCβ protein levels, increased PKCα translocation to the membrane, and accelerated O2 •- production that is eradicated by inhibition of PKCα or PKCδ (but not PKCβ). We conclude that increased PKCα expression and activity are primarily responsible for PKC-dependent O2 •- production by the mTAL during T1D.",
keywords = "Calphostin C, Chelerythrine, Diabetes mellitus, G{\"o}6976, Rottlerin",
author = "Jing Yang and Lane, {Pascale H.} and Pollock, {Jennifer S.} and Carmines, {Pamela K}",
year = "2009",
month = "11",
day = "1",
doi = "10.1152/ajprenal.00314.2009",
language = "English (US)",
volume = "297",
pages = "F1220--F1228",
journal = "American Journal of Physiology - Renal Physiology",
issn = "0363-6127",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - PKC-dependent superoxide production by the renal medullary thick ascending limb from diabetic rats

AU - Yang, Jing

AU - Lane, Pascale H.

AU - Pollock, Jennifer S.

AU - Carmines, Pamela K

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Type 1 diabetes (T1D) is a state of oxidative stress accompanied by PKC activation in many tissues. The primary site of O2•- production by the normal rat kidney is the medullary thick ascending limb (mTAL). We hypothesized that T1D increases O2•- production by the mTAL through a PKC-dependent mechanism involving increased expression and translocation of one or more PKC isoforms. mTAL suspensions were prepared from rats with streptozotocin-induced T1D (STZ mTALs) and from normal or sham rats (normal/sham mTALs). O2•- production by STZ mTALs was fivefold higher than normal/sham mTALs (P < 0.05). PMA (30 min) mimicked the effect of T1D on O2•- production. Exposure to calphostin C or chelerythrine (PKC inhibitors), Gö6976 (PKCα/β inhibitor), or rottlerin (PKCδ inhibitor) decreased O2•- production to <20% of untreated baseline in both normal/sham and STZ mTALs. PKCβ inhibitors had no effect. PKC activity was increased in STZ mTALs (P < 0.05 vs. normal/sham mTALs) and was unaltered by antioxidant exposure (tempol). PKCα protein levels were increased by 70% in STZ mTALs, with a ∼30% increase in the fraction associated with the membrane (both P < 0.05 vs. sham). PKCβ protein levels were elevated by 29% in STZ mTALs (P < 0.05 vs. sham) with no change in the membrane-bound fraction. Neither PKCδ protein levels nor its membrane-bound fraction differed between groups. Thus STZ mTALs display PKC activation, upregulation of PKCα and PKCβ protein levels, increased PKCα translocation to the membrane, and accelerated O2 •- production that is eradicated by inhibition of PKCα or PKCδ (but not PKCβ). We conclude that increased PKCα expression and activity are primarily responsible for PKC-dependent O2 •- production by the mTAL during T1D.

AB - Type 1 diabetes (T1D) is a state of oxidative stress accompanied by PKC activation in many tissues. The primary site of O2•- production by the normal rat kidney is the medullary thick ascending limb (mTAL). We hypothesized that T1D increases O2•- production by the mTAL through a PKC-dependent mechanism involving increased expression and translocation of one or more PKC isoforms. mTAL suspensions were prepared from rats with streptozotocin-induced T1D (STZ mTALs) and from normal or sham rats (normal/sham mTALs). O2•- production by STZ mTALs was fivefold higher than normal/sham mTALs (P < 0.05). PMA (30 min) mimicked the effect of T1D on O2•- production. Exposure to calphostin C or chelerythrine (PKC inhibitors), Gö6976 (PKCα/β inhibitor), or rottlerin (PKCδ inhibitor) decreased O2•- production to <20% of untreated baseline in both normal/sham and STZ mTALs. PKCβ inhibitors had no effect. PKC activity was increased in STZ mTALs (P < 0.05 vs. normal/sham mTALs) and was unaltered by antioxidant exposure (tempol). PKCα protein levels were increased by 70% in STZ mTALs, with a ∼30% increase in the fraction associated with the membrane (both P < 0.05 vs. sham). PKCβ protein levels were elevated by 29% in STZ mTALs (P < 0.05 vs. sham) with no change in the membrane-bound fraction. Neither PKCδ protein levels nor its membrane-bound fraction differed between groups. Thus STZ mTALs display PKC activation, upregulation of PKCα and PKCβ protein levels, increased PKCα translocation to the membrane, and accelerated O2 •- production that is eradicated by inhibition of PKCα or PKCδ (but not PKCβ). We conclude that increased PKCα expression and activity are primarily responsible for PKC-dependent O2 •- production by the mTAL during T1D.

KW - Calphostin C

KW - Chelerythrine

KW - Diabetes mellitus

KW - Gö6976

KW - Rottlerin

UR - http://www.scopus.com/inward/record.url?scp=70350736105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350736105&partnerID=8YFLogxK

U2 - 10.1152/ajprenal.00314.2009

DO - 10.1152/ajprenal.00314.2009

M3 - Article

C2 - 19741016

AN - SCOPUS:70350736105

VL - 297

SP - F1220-F1228

JO - American Journal of Physiology - Renal Physiology

JF - American Journal of Physiology - Renal Physiology

SN - 0363-6127

IS - 5

ER -